Health Education, Infertility, In Vitro Fertilization, Psychosocial Support Systems, Quality of Life
Conditions
Brief summary
Reproductive health problems, particularly infertility, affect 48 million couples globally, ranking as the fifth most serious global obstacle for women. Infertility can lead to significant psychosocial effects, including stress, anxiety, and depression, with women experiencing these impacts more severely than men. In vitro fertilization (IVF) offers a solution but comes with emotional, physical, and psychosocial challenges, particularly for women, who often experience fatigue, headaches, weight gain, and stress. Effective support mechanisms, such as information and education, are crucial in improving the IVF experience. Video-assisted educational programs have shown promise in enhancing knowledge and reducing stress during IVF treatment. However, there is a lack of studies evaluating their impact on the quality of life and psychosocial status of women undergoing IVF. This study aims to examine the effect of video-supported training on drug use, quality of life, and psychosocial status of women during IVF treatment, hypothesizing that it will improve quality of life, increase emotional capacity, and reduce anxiety.
Interventions
Video education on self-administered medications for women undergoing IVF treatment
Sponsors
Study design
Masking description
In the single-blind method, subjects do not know which of the experimental or control groups they were selected and therefore which method was applied to them. The researcher knows the subjects selected for the experimental and control groups, and therefore which method was applied to which subjects.
Intervention model description
Parallel Assignment Randomized Controlled Experimental Design
Eligibility
Inclusion criteria
* Being female * Undergoing infertility treatment * Aged 18-49 years * Owning a tablet, smartphone, or similar device * Having internet access * Undergoing IVF treatment for the first time
Exclusion criteria
* Previously received controlled ovarian stimulation treatment * Patients undergoing frozen embryo transfer * No internet access * Refusal to participate in the IVF medication teaching session
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Introductory Information Form | to both groups before the intervention | A 28-question form designed by researchers to gather sociodemographic, general health, obstetric, and gynecological history of the participants. |
| Screening Tool on Distress in Fertility Treatment's (SCREENIVF) | to both groups before the intervention and after oocyte aspiration (OPU) | A tool recommended by ESHRE to assess psychosocial risk factors in individuals undergoing infertility treatment. The Turkish version consists of 28 items measuring anxiety, social support, helplessness, acceptance, and depression. |
| Fertility quality of life tool (FertiQoL) | to both groups before the intervention and after oocyte aspiration (OPU) | A 36-item scale developed by Boivin et al. (2011) to assess the quality of life in individuals with fertility problems. The Turkish version was validated by Dural et al. (2016). |
| State-Trait Anxiety Inventory (STAI) | to both groups before the intervention and after oocyte aspiration (OPU) | A 40-item inventory developed by Spielberger et al. (1970) and adapted to Turkish by Öner and Le Compte (1983). The inventory measures situational anxiety (20 items) and trait anxiety (20 items). |
| Education Satisfaction Evaluation Form | to both groups after oocyte aspiration (OPU) | A form developed by researchers to assess satisfaction with medication education. It uses a 0-10 scale, with higher scores indicating greater satisfaction. The form for the experimental group will also record video viewing behavior. |
Countries
Turkey (Türkiye)